- World rank, all time
- #38,110 of 42,892
- Rank in Switzerland
- #392 of 429
- Research works
- 167 ▼ 48% vs 2013–17
- Citations
- 2.3k 13.8 per fractional work
- Top-10% rate
- 29.1% record average 16.5%
- Open access
- 47% world 28%
What does Medtronic (Switzerland) specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.7× the share of its output that it takes of world research.
- MedicineField · 26.9 works3.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
Who are the top researchers at Medtronic (Switzerland)?
Ranked on the composite score, Simon Eggington, Tim van den Heuvel and Javier Castañeda lead among researchers whose main affiliation is Medtronic (Switzerland).
- 1 Simon Eggington Switzerland · #1,076,792 worldwide 29 citations · 16 works
- 2 Tim van den Heuvel Switzerland · #1,371,497 worldwide 26 citations · 17 works
- 3 Javier Castañeda Switzerland · #1,551,952 worldwide 15 citations · 21 works
Which keywords describe research at Medtronic (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 1 Diabetes, Diabetes, Cardiovascular Disease, Complications, Continuous Glucose Monitoring and Hypoglycemia.
- Self-Management
- Healthcare Policy
- Digital Health
- Chronic Disease Management
- Glucose Control
- Type 2 Diabetes
- Autoimmunity
- Genetics
- Surgical Patients
- Infection Risk
- Spinal Cord Stimulation
- Intensive Care Unit
- Critical Care
- Risk Factors
- Primary Care
- Epidemiology
- Hypoglycemia
- Complications
- Diabetes
- Insulin Therapy
- Glycemic Control
- Type 1 Diabetes
- Cardiovascular Disease
- Continuous Glucose Monitoring
- Diabetes Mellitus
- Heart Failure
- Quality of Life
- Clinical Guidelines
- Mortality
- Complex Regional Pain Syndrome
- Hyperglycemia
- Inflammatory Response
- Echocardiography
- Global Burden
- HLA Genes
- Cardiovascular Outcomes
- Quality Improvement
- Cost-effectiveness Analysis
- Health Utility Measures
- Cost of Care
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycemic Control10▲ 170×4 topics
- Insulin Therapy9▲ 193×3 topics
- Type 1 Diabetes7▲ 219×2 topics
- Diabetes6▲ 35×4 topics
- Cardiovascular Disease6▲ 15×6 topics
- Complications6▲ 31×6 topics
- Continuous Glucose Monitoring5▲ 304×1 topic
- Hypoglycemia5▲ 304×1 topic
- Diabetes Mellitus4▲ 49×4 topics
- Epidemiology4▲ 2.4×11 topics
- Heart Failure4▲ 22×6 topics
- Primary Care3▲ 22×8 topics
- Quality of Life3▲ 5.2×10 topics
- Risk Factors3▲ 6.7×8 topics
- Clinical Guidelines3▲ 24×4 topics
- Critical Care2▲ 27×3 topics
- Mortality2▲ 11×6 topics
- Intensive Care Unit2▲ 49×2 topics
- Complex Regional Pain Syndrome2▲ 279×1 topic
- Spinal Cord Stimulation2▲ 279×1 topic
- Hyperglycemia2▲ 46×2 topics
- Infection Risk2▲ 140×1 topic
- Inflammatory Response2▲ 78×2 topics
- Surgical Patients2▲ 241×1 topic
- Echocardiography2▲ 18×4 topics
- Genetics2▲ 6.8×3 topics
- Global Burden2▲ 9.1×3 topics
- Autoimmunity2▲ 31×1 topic
- HLA Genes2▲ 116×1 topic
- Type 2 Diabetes2▲ 20×2 topics
- Cardiovascular Outcomes2▲ 80×1 topic
- Glucose Control2▲ 80×1 topic
- Quality Improvement1▲ 18×3 topics
- Chronic Disease Management1▲ 17×4 topics
- Cost-effectiveness Analysis1▲ 39×1 topic
- Digital Health1▲ 28×2 topics
- Health Utility Measures1▲ 39×1 topic
- Healthcare Policy1▲ 30×2 topics
- Cost of Care1▲ 89×1 topic
- Self-Management1▲ 48×1 topic
Which research topics does Medtronic (Switzerland) publish most on?
By volume in 2022–2025: Diabetes Management and Research, Pain Management and Treatment, Hyperglycemia and glycemic control in critically ill and hospitalized patients and Diabetes and associated disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 5 works
- 2 Pain Management and Treatment Anesthesiology and Pain Medicine 2 works
- 3 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 2 works
- 4 Diabetes and associated disorders Genetics 2 works
- 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 7 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 1 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 9 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 1 works
- 10 Pancreatic function and diabetes Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medtronic (Switzerland)'s research output changed?
Output in 2018–2022 was 48% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.